Antibody Treatments Boosted By President Trump Are Going Unused

The video discusses the challenges in administering COVID treatments, including unused doses, logistical issues, and staffing shortages. It highlights the public perception of antibody treatments, especially after President Trump's experience, and provides statistics on the distribution and usage of doses. The video also addresses confusion over treatment costs and insurance coverage, emphasizing the need for more research and data to guide treatment decisions.

What was the impact of President Donald Trump's use of Regeneron's antibody cocktail?

What should patients consider if they are thinking about receiving antibody treatment?